An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries), a disposable reservoir for insulin (inside the pump) and a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to connect the insulin reservoir to the cannula.
An insulin pump is an alternative to multiple daily injections of insulin by insulin syringes or an insulin pen and allows for flexible insulin therapy when used in conjunction with blood glucose monitoring and carbohydrate counting.
Market Analysis and Insights: Global Insulin Delivery Systems Market
The global Insulin Delivery Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Insulin Delivery Systems Scope and Market Size
The global Insulin Delivery Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Insulin Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Insulin Delivery Systems market is segmented into
Pens
Pumps
Pen Needles
Syringes
Segment by Application, the Insulin Delivery Systems market is segmented into
Patients/Homecare
Hospitals & Clinics
The Insulin Delivery Systems market is analysed and market size information is provided by regions (countries). Segment by Application, the Insulin Delivery Systems market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Insulin Delivery Systems market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Insulin Delivery Systems business, the date to enter into the Insulin Delivery Systems market, Insulin Delivery Systems product introduction, recent developments, etc.
The major vendors covered:
Becton, Dickinson and Company
Novo Nordisk
Medtronic
Sanofi
ELI Lilly and Company
Ypsomed Holding
Animas Corporation
Tandem Diabetes Care
Insulet Corporation
Biocon
An insulin pump is an alternative to multiple daily injections of insulin by insulin syringes or an insulin pen and allows for flexible insulin therapy when used in conjunction with blood glucose monitoring and carbohydrate counting.
Market Analysis and Insights: Global Insulin Delivery Systems Market
The global Insulin Delivery Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Insulin Delivery Systems Scope and Market Size
The global Insulin Delivery Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Insulin Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Insulin Delivery Systems market is segmented into
Pens
Pumps
Pen Needles
Syringes
Segment by Application, the Insulin Delivery Systems market is segmented into
Patients/Homecare
Hospitals & Clinics
The Insulin Delivery Systems market is analysed and market size information is provided by regions (countries). Segment by Application, the Insulin Delivery Systems market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape
and Insulin Delivery Systems Market Share AnalysisInsulin Delivery Systems market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Insulin Delivery Systems business, the date to enter into the Insulin Delivery Systems market, Insulin Delivery Systems product introduction, recent developments, etc.
The major vendors covered:
Becton, Dickinson and Company
Novo Nordisk
Medtronic
Sanofi
ELI Lilly and Company
Ypsomed Holding
Animas Corporation
Tandem Diabetes Care
Insulet Corporation
Biocon
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.